RemedyRePack Inc. recalls Clindamycin HCl Capsule
- Published
- 14 May 2025
- Units affected
- 23 bottles/30 count- 690 capsules
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
- Brand / company
- RemedyRePack Inc.
- Codes / lots
- Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
- Distribution
- Within U.S - PA, VA, FL.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.